You are on page 1of 4

Running head: ELEVATOR SPEECH SENATE BILL 114

Elevator Speech Senate Bill 114


Angela Long
Coppin State University
Helen Fuld School of Nursing
Masters in Nursing Family Nurse Practitioner Program
Health Systems Policy, Organizations, and Financing
Nurs 505
Dr. Nayna Philipsen, JD, RN
April 03, 2013
Elevator Speech Senate Bill 114
A. Identify yourself.
B.
1. Angela Long RN, BSN nursing student
C. Identify and summarize a bill introduced in the current Maryland legislative Session and
approved by faculty for this presentation.
D.
1. Senate Bill 114 is a bill that requires any medical provider attending to a women for
pregnancy to submit to a medical laboratory , a blood sample taken from the women
when the women first presents for examination and if the women has not had prenatal
services or there is no documentation of the womens hepatis B status (Senate Bill 114,
2013, p. 1).
2. A women may object to the testing for religious beliefs and practices(Senate Bill 114,
2013, p. 1).
3. The Bill also states that the laboratory must perform a standard hepatitis B test that is
approved by the Department of Health and Mental Hygiene (Senate Bill 114, 2013, p. 1).
E. Identify Stakeholders who support, and why?
F.
1. US Centers for Disease Control and Prevention (Senate Bill 114, 2013, p. 1)
2. Department of Health and Mental Hygiene(Senate Bill 114, 2013, p. 1)

3. Senator Benson and Montgomery(Senate Bill 114, 2013, p. 1)


G. Identify Stakeholders who oppose, and why?
1. No one opposed this bill, it was voted on third reading and received 47 yeas and 0
nays on March 7 and had its first and second hearings in the house which were
favorable.
2. The Progress of a Bill ( Handout).
3. The DHMH has advised that this testing is already a recommendation of standard of
care and will cause no increase in health care cost, already covered by Medicaid and
will not affect state finances or operations, no local effect, no small business effect
(Senate Bill 114, 2013, p. 1)
4. The only potential harm of screening for HBV is false positives, which can lead to
psychological harms, increase cost of subsequent testing and unnecessary treatments
(Lin & Vickery, 2009, p. 876). Currently there are no studies published against HBV
testing (Lin & Vickery, 2009, p. 876).
H. Give your rationale for Supporting or Opposing the bill.
I.
1. HBV is a major cause of morbidity and morality worldwide , of which chronic
HBV can cause cirrhoisis, hempatic decompensation and hepatocellular carcinoma and
even death (Aspinall, Hawkins, Fraiser, Hutchinson, & Goldberg, 2011, p. 1). It is also
noted to be the major cause for liver transplants worldwide (Senate Bill 114, 2013, p. 2).
2. Transmission can occur vertically from mother to child, horizonally from child to
child within a household, sexually, or parenterally such as iv drug use, sharps injury
or contaminated blood products (Aspinall et al., 2011, p. 2).
3. In 2004 US preventive services task force recommended HBV screening for women
on the first prenatal visit that way positive women could revieve treatment and their
infants could receive prophylaxis treatment immediately following birth(Lin &
Vickery, 2009, p. 874).
4. Not all medical providers practice the same way. The literature that is currently
published states that only 60% of medical providers offer testing for HBV and HIV as
a option and this differs from urban to rural areas.
5. Medical community continues to argue over the transmission of HBV via the
breastmilk and is another concern facing HBV positive mothers (Yogeswaran &
Fung, 2011, p. 6)
6.
7.
8.
9.
10.
11.

ELEVATOR SPEECH SENATE BILL 114

References
Aspinall, E., Hawkins, G., Fraiser, A., Hutchinson, S., & Goldberg, D. (2011). Hepatitis B
prevention, diagnosis, treatment and care : a review. Occupational Medicine, 61(1), 531540. http://dx.doi.org/10.1093/occmed/kqr136
Frischknecht, F., Sell, W., Trummer, I., & Bruhwiler, H. (2011, Janurary 6). Serological testing
for infectious diseases in pregnant women: are the guidelines followed? The European
Journal of Medical Science, 1-5. http://dx.doi.org/10.4414/smw.2011.13138
Giles, M., Garland, S., Grover, S., Lewin, S., & Hellard, M. (2006, April 16). Impact of an
education campaign on management in pregnancy of women infected with a blood-borne
virus. MJA, 184(8), 389-392. http://dx.doi.org/
Giles, M., Sasadeusz, J., Garland, S., Grover, S., & Hellard, M. (2004, April 4). An audit of
obstetricians management of women potentially infected with blood-borne virsues. MJA,
180(1), 328-332. http://dx.doi.org/
Hu, Y., Zhang, S., Luo, C., & Zhou, Y. (2012). Gaps in the prevention of perinatal transmission
of hepatitis B virus between recommendations and routine practices in a highly endemic
region: a provincial population-based study in China. Biomed Central, 1-7.
http://dx.doi.org/10.1186/1471-2334-12-221
Lin, K., & Vickery, J. (2009, June 16). Screening for hepatitis B virus infection in pregnant
women: evidence for the U. S. preventive services task force reaffirmation
recommendation statement. Annals of Internal Medicine, 150(12), 874-876. Retrieved
from www.annals.org
Senate Bill 114 [Press release]. (2013, March 22, 2013). Retrieved from
http://mgaleg.maryland.gov

ELEVATOR SPEECH SENATE BILL 114


Yogeswaran, K., & Fung, S. (2011, February 25). Chronic hepatitis B in pregancy: unique
challeges and opportunties. The Korean Journal of Hepatology, 17(1), 1-8.
http://dx.doi.org/